180 Degree Capital Corp.'s Portfolio Company, Mersana Therapeutics Inc., Completes Initial Public Offering

Stock Information for 180 Degree Capital Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About 180 Degree Capital Corp.

180 Degree Capital Corp. Notes Inclusion of Matthew F. McLaughlin as a Nominee for the Board of Directors of comScore, Inc.
180 Degree Capital Corp. Notes Average Discount of Net Asset Value per Share to Stock Price for Third Month of Initial Measurement Period of its Discount Management Program
180 Degree Capital Corp. Notes Support of Its Board Nominee, Matthew F. Mclaughlin, by Board of Directors of comScore, Inc.
180 Degree Capital Corp. Notes Average Discount of Net Asset Value Per Share to Stock Price for Second Month of Initial Measurement Period of its Discount Management Program
180 Degree Capital Corp. Reports Net Asset Value per Share ("NAV") of $5.02, Comprised of 99% Cash and Public Securities, as of December 31, 2023
180 Degree Capital Corp. to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024, and to Host a Conference Call on Wednesday, February 21, 2024
180 Degree Capital Corp. Notes Average Discount of Net Asset Value Per Share to Stock Price for First Month of Initial Measurement Period of Its Discount Management Program
180 Degree Capital Corp. Nominates Matthew F. McLaughlin for Election to the Board of comScore, Inc.

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.